Get access to free course material to start learning Python. Learn important skills and tools used in programming today. Test ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 generic drug makers are expected to begin launching their cheaper versions ...

Indian firms such as Ajanta Pharma, Dr Reddy's Laboratories, Lupin, Mankind Pharma and Sun Pharmaceuticals are poised to fulfil domestic demand for weight-loss drugs with more affordable generic ...

Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

NASHVILLE, Tenn. — The Tennessee Attorney General's Office announced that states across the country reached new settlements totaling $17.85 million with two drug companies over alleged generic ...

Credit: Cosette Pharmaceuticals Cosette’s Ciprofloxacin Hydrochloride 0.2% and Hydrocortisone 1% Otic Suspension is supplied as a suspension in a 10mL bottle with a dropper dispenser. A generic option ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines. Dr. Reddy’s, an Indian generic ...

The Python Software Foundation has rejected a $1.5 million government grant because of anti-DEI requirements imposed by the Trump administration, the nonprofit said in a blog post yesterday. The grant ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...